Assessing Albemarle (ALB) Valuation After Recent Mixed Short Term Share Price Moves
Albemarle Corporation ALB | 0.00 |
Albemarle stock snapshot after recent trading moves
Albemarle (ALB) has caught investor attention after recent trading, with the stock closing at $171.58. Short term performance has been mixed, with a small gain over the past day but declines over the past week and month.
That short term rebound contrasts with weaker recent share price momentum. The 30 day share price return is down 8.89%, while the year to date share price return of 19.21% sits against a very large 1 year total shareholder return of 203.06%.
If Albemarle has you thinking about where capital could move next in materials and energy storage, it can be useful to scan 27 best rare earth metal stocks
With Albemarle stock pulling back in recent weeks yet still showing a very large 1 year return, investors are left asking whether today’s price reflects a discount or if the market is already pricing in future growth.
Most Popular Narrative: 60% Undervalued
Albemarle's most followed narrative places fair value at $172.62, almost exactly in line with the last close near $171.58, yet still frames the stock as materially undervalued versus its modeled future cash flows.
The analyst price target for Albemarle has been raised from about $148 to roughly $173. This change reflects analysts' use of a slightly lower discount rate, modestly higher revenue growth assumptions, and a higher future P/E multiple, supported by a series of recent target hikes and upgrades tied to stronger lithium pricing and tightening supply expectations.
Curious what kind of revenue path, margin rebuild, and earnings multiple are being plugged in to reach that fair value line so close to today’s price? The core narrative leans on a specific mix of growth, profitability recovery, and a richer future valuation multiple that is usually reserved for higher quality compounders. If you want to see exactly which long term assumptions underpin that view, the full narrative lays out the numbers that sit behind that $172.62 figure.
Result: Fair Value of $172.62 (UNDERVALUED)
However, that upside story can break quickly if lithium prices stay weak for longer or if oversupply and tougher regulations squeeze Albemarle's margins and expansion plans.
Another angle on Albemarle’s valuation
The SWS DCF model paints a very different picture, with Albemarle trading around $171.58 versus an estimated future cash flow value of $351.48, or about 51% below that level. When one model suggests the stock is expensive and another suggests it is cheap, which signals do you trust more?
Next Steps
With mixed signals on valuation and sentiment running both hot and cold, this is the moment to review the data yourself, weigh the upside against the concerns, and decide how Albemarle fits your plan by checking the 2 key rewards and 1 important warning sign.
Looking for more investment ideas?
If Albemarle has sharpened your focus, do not stop here. Use these ideas to quickly surface fresh opportunities that might suit your style and risk appetite.
- Target potential mispricings by scanning 49 high quality undervalued stocks and see which stocks currently sit on investors' blind side.
- Strengthen your income stream by reviewing 10 dividend fortresses and spot companies offering meaningful yields with staying power.
- Reduce stress in your portfolio by assessing 67 resilient stocks with low risk scores and focus on businesses that score well on resilience.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
